Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.05K Sell
38
-2
-5% -$242 ﹤0.01% 1335
2026
Q1
$6.54K Buy
40
+38
+1,900% +$5.84K ﹤0.01% 1137
2025
Q4
$348 Buy
+2
New +$365 ﹤0.01% 1266
2025
Q2
– Sell
-6
Closed -$458 – 1363
2025
Q1
$458 Buy
+6
New +$459 ﹤0.01% 1323

Other funds holding INSM

CVA Family Office's INSM Position: Q2 2026 in Review

CVA Family Office reduced its Insmed (INSM) stake by 5% in Q2 2026, selling an estimated $242 and leaving 38 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

CVA Family Office first reported a position in INSM in Q1 2025 and has held it in 4 quarters since. The position peaked at $6.54K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • CVA Family Office held 38 shares of Insmed worth $4.05K as of Q2 2026.
  • CVA Family Office sold 2 Insmed shares in Q2 2026, an estimated $242.
  • Insmed made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1335 holding.
  • CVA Family Office first reported a position in Insmed in Q1 2025 and has held it in 4 quarters since.
  • CVA Family Office's Insmed position peaked at $6.54K in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.